RespireRx Pharmaceuticals Inc (RSPI)

[gfp927z]

Neuro, I just don't see how you can draw that conclusion so confidently since it requires a considerable leap of faith. Your argument appears to rest on the presumption that the FDA wouldn't have liberalized the AD PET dose unless they were also planning to liberalize the dose all around, the rationale including various FDA public relations perceptions related to their thoroughness and safety, etc as you elaborated in a previous post. That's fine, but face it, the conclusion involves a leap of faith, so presenting it as a virtual done deal sounds a little bit like one of my ill advised slam dunk pronouncements. That said, I think you're conclusion will turn out to be correct BTW.